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Objective: The acute and long-term benefits of internal thoracic artery grafting are
clear in younger patients undergoing coronary artery bypass grafting. The elderly,
however, face higher surgical risks and have shorter life expectancy, and thus the
use of internal thoracic artery grafting in this age group has been debated. This study
examined the use, complication risks, and operative (30-day) mortality associated
with internal thoracic artery grafting in patients 75 years of age and older.
Methods: Between 1996 and 1999, 522,656 patients in the Society of Thoracic
Surgeons National Cardiac Database underwent primary, nonemergency-salvage
coronary artery bypass grafting; of these, 99,942 were 75 years of age or older. The
influence of internal thoracic artery use on operative mortality and 5 major com-
plications in this elderly group was examined by means of (1) risk adjustment
(adjusting for 28 baseline risk factors and site) and (2) a treatment propensity score
analysis that compares patients with similar baseline likelihood for receiving an
internal thoracic artery graft.
Results: In the National Cardiac Database 77.4% of patients aged 75 to 84 years
received an internal thoracic artery graft compared with 93.5% for those aged 55
years or less. In this elderly group use of the internal thoracic artery was strongly
associated with decreased operative mortality (unadjusted mortality, 6.20% vs
4.05%; P  .0001) that persisted after controlling for baseline risk and provider
effects (adjusted odds ratio, 0.85; 95% confidence intervals, 0.79-0.91). This mor-
tality benefit was seen among those with low-to-high baseline propensity for
receiving an internal thoracic artery graft.
Conclusions: Use of the internal thoracic artery in elderly patients undergoing coronary
artery bypass grafting provides an acute survival benefit. This benefit is similar to that
seen in younger patients and persists after adjusting for both patient and provider
selection factors. The internal thoracic artery appears to be underused in elderly patients
undergoing bypass grafting and is a potential area for quality improvement.
The procedure of coronary artery bypass grafting (CABG) is the mostexamined intervention in medical history. Over the past 30 years,studies have addressed overall CABG outcomes versus those ofalternative therapies, as well as the effect of technical improvementsin the procedure itself.1-4 Among the most powerful of these tech-nical improvements has been the grafting of the left internal thoracic
artery (ITA) to the left anterior descending coronary artery (LAD). First introduced
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by Green,5 its efficacy was established in the seminal report
by Loop and colleagues3 in 1986, demonstrating the bene-
ficial long-term survival effect of ITA grafting. Subsequent
studies established the superiority of the ITA versus the
saphenous vein in terms of long-term patency.6
In 1994, the first report analyzing the effect of ITA
grafting on acute (30-day) survival after CABG was pub-
lished by Edwards and associates.7 Using the Society of
Thoracic Surgeons (STS) National Cardiac Database (NCD)
in an analysis of 38,578 patients, this study demonstrated
that higher risk patients benefited from ITA grafting in
terms of improved mortality. However, only 48% of pa-
tients in the NDB during this era (1987-1991) received an
ITA graft, and only 15% were aged 75 years or older. Since
then, the use of ITA grafting has increased significantly,8,9
and its use has become recognized as a marker of quality of
care.10-13
Although few dispute the acute and long-term benefits of
ITA grafting in younger patients undergoing CABG, the
risk versus benefit of ITA grafting in high-risk patients is
less clear, as recently elucidated by Cohn.14 At the top of
this high-risk list are the septuagenarians, octogenarians,
and nonagenarians presenting for revascularization.15,16
Specifically, the elderly face higher mortality and postop-
erative complication risks, and it can be questioned whether
any operative technique that might further increase these
risks is worthwhile. Finally, because the elderly have a
shorter natural life expectancy after CABG, some have
questioned ITA use in this setting because the long-term
survival benefits are less likely to be realized. As the mean
age of patients undergoing CABG continues to increase, a
reevaluation of ITA therapy in this subgroup seems war-
ranted.
We therefore undertook this study to evaluate contem-
porary-era use of ITA grafting in the STS National Data-
base. Because of the question of efficacy in the aged pop-
ulation (ie, 75 years), we analyzed the use and
complications associated with ITA grafting in this popula-
tion.
Methods
Data Collection
STS NCD data are harvested semiannually from sites nationwide
performing cardiac surgery. Through 1999, the Adult Cardiac
Database contained 1.54 million patient records. Data are ware-
housed at the Duke Clinical Research Institute (DCRI) in Durham,
NC, and the Outcomes Group at DCRI performs the statistical
analyses for the reports and scientific investigations. Site-specific
feedback reports are generated semiannually for the local partici-
pants for outcomes analysis and quality-improvement efforts. In
addition, regional reports for state and regional groups around the
country are produced for the purposes of regional quality-improve-
ment activities.
Study Population
The study population was derived from the patients in the STS
NCD who underwent isolated, first-time CABG between 1996 and
1999. Excluded were patients who had a concomitant valve or
other cardiac procedures and patients undergoing reoperation. Also
excluded were patients who presented for emergency or salvage
intervention according to the STS definition because emergency or
salvage status strongly affects the decision to use an ITA graft.
Under emergency conditions, some patients are not eligible for
ITA grafting, but variables in the NCD are not available to distin-
guish these patients from those who are eligible. Thus only elective
and urgent cases were included in the analysis.
This study population data set was harvested from a total of 495
sites; there were 9 additional sites at which the ITA use was less
than 40%, and these sites were excluded from the analysis for
data-quality reasons. Finally, patient records in which ITA grafting
data were missing or the 2 ITA-related variables in the NCD data
set were inconsistent were excluded as well. These latter 2 exclu-
sions were for data-quality reasons.
Statistical Methods
The purpose of this analysis was to examine the effect of ITA
grafting in the elderly on operative (30-day) mortality and on
major morbidity categories of prolonged ventilation, mediastinitis,
repeat surgical intervention (any reason), postoperative acute renal
failure, and postoperative stroke. Because of the observational
nature of the data, it was important to consider the possibility of
confounding, namely that healthier patients may receive an ITA
graft or that sites that more often use an ITA graft may focus on
quality and generally have better outcomes. Either of these cir-
cumstances could cause the use of an ITA graft to appear to be
more effective than it actually is. We used 2 statistical methods
that account for both patient- and site-level confounding to eval-
uate the influence of ITA grafting.
Multivariate logistic analysis. First, a random-effects
logistic model was used to test for the effect of ITA grafting
on mortality and complications after adjusting for 28 base-
line patient risk factors (of the total of 106 variables col-
lected for an isolated CABG procedure), as well as site (as
a random effect) and the percentage of ITA use at the site.
Risk-adjusted odds ratios (ORs) with 95% confidence inter-
vals (CIs) provide estimates of the within-site effect of ITA
use.17,18
Patients were divided into 5 groups on the basis of their
preoperative risk scores (obtained from risk-adjustment
model with ITA excluded) to determine whether the effect
varied according to patient risk, and mortality rates for
patients receiving an ITA graft and those not receiving an
ITA graft were calculated.
Finally, an analysis of interaction between ITA use and
all other variables was also performed to determine whether
the effect of ITA grafting remained constant across levels of
the other variables.
Propensity score analysis. Second, a treatment propen-
sity score analysis was performed.19 A random-effects lo-
gistic model that included both patient risk factors and a site
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effect was used to determine the propensity for receiving an
ITA graft. ORs and 95% CIs were generated for each
variable included in the model. These variables encompass
all the relevant risk factors in the STS CABG mortality
model, which has been extensively validated. The same 28
variables used in the mortality model were used in the
propensity model analysis because the bias caused by leav-
ing out a weakly predictive confounding variable dominates
the efficiency gained from not using that variable.20 The
patients were then divided into 5 quintiles of equal size on
the basis of their propensity scores. An overall test of the
association of ITA grafting on mortality was performed by
using the Mantel-Haenszel test.
In an additional step, patients were also matched on
propensity score, and the effect of ITA grafting was exam-
ined in this pair-matched group.
Survey Data
A survey tool was developed and distributed to 495 respondent
sites that participate in the NCD to assess the prevailing assump-
tions regarding ITA grafting in the elderly among practicing STS
participants. This tool surveyed a site’s opinion regarding ITA use
in the elderly, consistency of this opinion with current practice,
and a percentage estimate of patients older than 75 years who
received an ITA graft at their institution.
Results
Through 1999, a total of 1,517,765 patient records have
been harvested into the Adult Cardiac Database of the STS.
Between 1996 and 1999, a total of 687,112 patients who
underwent isolated CABG of all preoperative status catego-
ries (elective, urgent, emergency, and salvage) were har-
vested. The 48,241 emergency or salvage patients were
excluded, as were the 50,397 patients who had previously
undergone a CABG procedure. After excluding sites at
which the ITA use was less than 40%, the data set contained
540,148 patients (106,075 age 75 years); after excluding
missing or conflicting ITA data, the final data set was
comprised of 522,656 patients, with 99,942 patients 75
years or older.
Use of ITA in the STS National Database
During the study period for this analysis (1996-1999), ITA
use reached a plateau at approximately 85% for the overall
population compared with 48% in the earlier STS report
from 1987 to 1991.7 Use in the population 75 years or older
has lagged behind that in the total population by about 10%
to 15% annually during this time period.
Figure 1 shows ITA use by age group in the NCD for the
study period. Of elective or urgent patients aged 20 to 54
years, 93.5% received an ITA. This use declined after age
74 years to only 57.8% in the 85-year-old age group. In
1999, the percentage of ITA use was 89.9% for the total
population and 80.8% for patients 75 years or older (com-
pared with 77.4% for the 3-year average).
The use of an ITA in the elderly varied considerably
among the 495 sites included in this study. The 25th per-
centile, median, and 75th percentile of use of an ITA in this
elderly population was 53%, 72%, and 86%, respectively.
Risk Adjustment
Table 1 shows the descriptive statistics comparing the
23,700 patients over age 75 years without ITA grafting with
the 76,242 patients with ITA grafting. The univariate com-
parison differences were statistically significant for all vari-
ables except diabetes. The mean age of the population was
79 years, which is significantly older than any data set of
this size previously reported. The group not receiving an
ITA graft was older and had more women. This group also
had a higher incidence of preoperative arrhythmias, preop-
erative shock and congestive heart failure, chronic lung
disease, stroke, and preoperative dialysis and a slightly
lower ejection fraction (EF). The incidence of preoperative
intra-aortic balloon pumping and left main and triple-vessel
disease was higher as well. There was also a higher inci-
dence of patients coming to the surgical department classi-
fied as urgent preoperative status.
Table 2 shows unadjusted outcomes for mortality and
major morbidity categories. Mortality before risk adjust-
ment was higher in the group not receiving an ITA graft, as
Figure 1. ITA use by age grouping in the STS NCD. The percentage
of ITA use declines significantly after age 65 years. The numbers
above the bars indicate the number of patients in that age group
subset. Total numbers for these subgroups include the following:
age 20-54 years, 94,017/100,520; 55-64 years, 128,230/139,512; 65-74
years, 161,860/182,682; 75-84 years, 72,975/94,287; and 85 years and
older, 3267/5655.
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was the postoperative incidence of stroke, prolonged venti-
lation, reoperation for any reason, and renal failure. Deep
sternal infection was higher in the ITA group, but the
incidence was small (0.52% in the group not receiving an
ITA graft vs 0.66% in the group receiving an ITA graft).
Mean total length of stay and postoperative length of stay
were also longer in the group not receiving an ITA. For
unadjusted mortality and stroke, prolonged ventilation, re-
TABLE 1. Overall descriptive statistics for patients age 75 years or greater, STS National Database
Variable Data type Level
No ITA
(n  23,700)
ITA
(n  76,242) P value
Age (y) Mean 79.63 78.27 .0001
Median 79.00 78.00
25th 77.00 76.00
75th 82.00 80.00
Arrhythmia % Yes 20.73 17.36 .0001
BSA Mean 1.79 1.84 .0001
Median 1.81 1.86
25th 1.66 1.72
75th 1.95 2.00
Cardiogenic shock % Yes 2.43 1.50 .0001
CHF % Yes 23.86 16.36 .0001
Chronic lung disease % Yes 19.03 14.82 .0001
NYHA class IV % Yes 27.16 22.99 .0000
CVA % 2 wk 10.34 8.72 .0001
% 2 wk 0.42 0.31 .0001
CVD % Yes 17.53 15.37 .0001
Diabetes % Yes 27.91 27.93 .9599
Dialysis % Yes 1.04 0.58 .0001
Female % Yes 47.59 36.86 .0001
EF Mean 49.13 50.94
Median 50.00 50.00 .0001
25th 40.00 45.00
75th 59.00 60.00
Preoperative IABP % Yes 6.44 3.78 .0001
Left main disease % Yes 25.03 23.32 .0001
MI % 21 d 24.23 24.06 .0001
% 1-21 d 24.89 21.17 .0001
% 24 h 1.33 0.84 .0001
% 6 h 0.66 0.32 .0001
PVD % Yes 20.46 18.43 .0001
Race % Yes 7.50 6.03 .0001
Renal failure % Yes 7.69 5.55 .0001
Triple-vessel disease % Yes 73.42 75.62 .0001
Urgent status % Yes 39.10 35.12 .0001
BSA, Body surface area; CHF, congestive heart failure; NYHA, New York Heart Association; CVA, cerebrovascular accident (stroke, permanent); CVD,
cerebrovascular disease; IABP, intra-aortic balloon pump; MI, myocardial infarction; PVD, peripheral vascular disease.
TABLE 2. Unadjusted outcomes of mortality and 5 major morbidities after primary elective or urgent CABG for patients older
than 75 years in the STS NDB, 1996-1999 (n  99,942)
Outcome No ITA ITA Unadjusted OR (95% CI)
Mortality 6.20 4.05 0.64 (0.61-0.68)
Complications
Stroke, permanent (%) 3.24 2.76 0.85 (0.78-0.92)
Prolonged ventilation (%) 10.11 7.08 0.68 (0.64-0.71)
Reoperation for any reason (%) 7.42 6.18 0.82 (0.78-0.87)
Renal failure (%) 6.82 5.44 0.79 (0.74-0.83)
Deep sternum infection (%) 0.52 0.66 1.28 (1.05-1.55)
Length of stay (median [25th-75th]) 10 (7-14) 8 (6-12)
Postoperative length of stay (median [25th-75th]) 7 (5-9) 5 (4-6)
Surgery for Acquired Cardiovascular Disease Ferguson, Coombs, Peterson
872 The Journal of Thoracic and Cardiovascular Surgery ● May 2002
A
CD
operation, and renal failure, the unadjusted OR and 95% CI
levels were below 1.0.
Table 3 illustrates the risk-adjusted outcomes, as deter-
mined by using the random-effects logistic model. Included
in the model was a random site effect, as well as a variable
indicating the percentage of ITA use at that site.17 Including
these variables in the model allowed for estimation of the
effect of ITA grafting after controlling for confounding
caused by site. The presence of an ITA graft significantly
improved 30-day survival and was associated with a signif-
icant decrease in prolonged ventilation in this elderly pop-
ulation of patients. The risk-adjusted ORs for reoperation,
stroke, and renal failure were less than 1.0 but did not reach
statistical significance. There was a significant increase in
the risk-adjusted OR for deep sternal infection.
Patients were divided into 5 groups on the basis of their
preoperative risk scores to determine whether the improve-
ment in 30-day mortality varied according to preoperative
patient risk class, and mortality rates for the groups receiv-
ing and not receiving an ITA graft were compared. These
predicted risk scores were obtained from the risk model
with ITA excluded. Figure 2 shows that mortality rates for
those receiving an ITA were lower than rates for those not
receiving an ITA in each of the 5 predicted risk groups.
An examination of potential interactions of ITA use with
baseline risk variables yielded 2 significant interactions,
namely for age and EF. In subgroup analysis (Figure 3) the
acute survival benefits of an ITA graft appear to diminish in
those aged 85 years or older. Subgroup analysis also dem-
onstrated that as EF decreases, the benefit of ITA grafting
on operative mortality declines as well; the patients with
moderate (30  EF  45) and severe (30) dysfunction
demonstrated a trend toward survival that did not achieve
statistical significance.
Propensity Score Analysis19
A total of 29 variables were used to develop a propensity for
receiving an ITA graft for each member of the population
75 years of age or older. The ORs, CIs, t values, and P
values for these variables are shown in Table 4 and are
sorted in order of their predictive power on the basis of the
absolute value of t. Variables with a negative t value con-
tributed to a negative propensity for ITA use; among these
were female sex, chronic lung disease, preoperative intra-
aortic balloon pumping, and preoperative congestive heart
failure. Alternatively, the propensity for an ITA graft was
increased by increased body surface area, better EF, and left
main and triple-vessel disease. This propensity analysis
included the adjustment for the site effect.17,18
Table 5 illustrates the grouping of the total population
into quintiles on the basis of these assigned propensity
scores. Patients who received an ITA graft were then com-
pared with those who did not within each quintile. The
lowest propensity score group had only 38.5% use of an
ITA, whereas the highest propensity score group had a
97.8% use rate.
For each propensity score group the mortality rates were
lower in the group receiving an ITA graft. The overall
association of ITA use and mortality in the propensity score
analysis was highly significant (P  .0001, Mantel-Haens-
zel test). Within-group mortality differences ranged from
0.34 in the low-propensity group to 2.29 in the high-pro-
pensity group. Thus even in the group with the lowest
propensity for ITA grafting preoperatively, an acute sur-
vival benefit was accrued by ITA grafting. Stated another
way, there was no propensity score group that did not
benefit from ITA grafting. The average difference in mor-
tality was 1.29 across the 5 propensity groups.
The matched-pair analysis also demonstrated a benefit to
ITA grafting. Importantly, there were only 220 patients of
TABLE 3. Risk-adjusted outcomes using logistic regression
models: Risk-adjusted mortality and major postoperative
morbidity for ITA grafting in the elderly (age >75 years,
n  99,942)
Outcome Risk-adjusted OR (95% CI)
Mortality 0.85 (0.79-0.91)
Complications
Stroke, permanent (%) 0.98 (0.90-1.08)
Prolonged ventilation (%) 0.86 (0.81-0.91)
Reoperation for any reason (%) 0.95 (0.89-1.01)
Renal failure (%) 0.95 (0.88-1.01)
Deep sternum infection (%) 1.36 (1.12-1.65)
The analysis includes adjustment for the site effect, as described in the
“Methods” section.
Figure 2. ITA use by preoperative risk group in patients 75 years
of age and older. The 5 predicted risk groups were based on
preoperative risk assessment in a model without ITA use as a
variable. These data suggest that ITA grafting conveys a benefit in
each of the 5 risk groups, including the lowest risk group. OM,
Observed mortality.
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the total 99,942 patients that could not be matched to 0.01.
This analysis showed a strong benefit of ITA use versus not
receiving an ITA (OR, 0.73; 95% CI, 0.69-0.76).
Discussion
The STS National Database
This is the second report on the influence of ITA graft use
on acute (30-day) mortality from the STS National Data-
base.7 The present study documents that a significant sur-
vival benefit is accrued by means of routine ITA grafting in
a patient population considerably older than any previously
reported. These results are gratifyingly similar to those
reported for younger patients.
Benefits of ITA Grafting: Patency and Long-term
Survival
Improved late survival resulting from in situ left ITA graft-
ing has been well documented through a number of large,
single-institution analyses.3,5,6 The mechanism for this im-
proved patency is thought to relate to the arterial nature of
the conduit with its associated biochemical and physiologic
characteristics absent in venous conduits, the in situ nature
of the graft with only a single (distal) anastomosis, the more
anatomic size match between the conduit and the recipient
native coronary artery,14,21 and the relative lack of propen-
sity for development of atherosclerotic arterial disease.5,22,23
In one of these studies, Lytle and colleagues24 concluded
that bilateral ITA grafting conveys an additional benefit
over single ITA grafting in terms of late (12-year) mortality,
freedom from reoperation, and percutaneous transluminal
coronary angioplasty intervention. Bilateral grafting im-
proved survival over single ITA grafting, even in the sub-
group that was more elderly at the time of the operation. In
an accompanying analysis of the same data set, Blackstone
and Lytle25 demonstrated that the late death incidence after
either single or bilateral ITA grafting increases with the age
at the nascent operation. However, only 3.1% of patients
receiving bilateral ITA grafts and 11.0% of patients receiv-
ing single ITA grafts in this analysis were older than 70
years at the time of initial surgical intervention in this data
set.
Few, if any, other studies contain significant numbers of
elderly patients (as defined in this analysis), and long-term
survival was not a focus of the present study. Thus the
importance of long-term survival in considering the use of
an ITA graft in elderly patients undergoing CABG remains
unclear. Many surgeons have foregone ITA grafting in these
patients on the presumption that this long-term benefit
might never be realized. However, it would be surprising if
the findings from younger patients could not be extrapolated
to older patient subsets, particularly those in the 75- to
80-year age group without associated disease processes. The
percentage of elderly patients presenting for revasculariza-
TABLE 4. Listing of variables used to develop propensity
score for the propensity score analysis
Variable OR
Lower
95% CI
Upper
95% CI t Value P value
Participant .0001
Age 0.86 0.86 0.87 55.77 .0001
Female sex 0.69 0.66 0.72 17.31 .0001
Chronic lung 0.69 0.66 0.72 16.05 .0001
BSA 2.17 1.96 2.41 14.44 .0001
EF 1.01 1.01 1.01 14.05 .0001
IABP 0.65 0.60 0.70 10.67 .0001
CHF 0.79 0.75 0.83 9.70 .0001
Triple-vessel disease 1.19 1.14 1.24 8.52 .0001
Steroids 0.71 0.65 0.77 7.87 .0001
First reoperation 0.47 0.38 0.58 6.92 .0001
Nitrates 0.88 0.84 0.91 6.08 .0001
Diuretics 0.89 0.86 0.93 5.56 .0001
Urgent status 0.89 0.85 0.93 5.40 .0001
MI 0.95 0.93 0.97 5.11 .0001
Arrhythmia 0.90 0.86 0.94 4.81 .0001
CVA 0.87 0.82 0.92 4.62 .0001
Shock 0.76 0.67 0.86 4.41 .0001
Dialysis 0.69 0.57 0.84 3.65 .00
Digitalis 0.91 0.87 0.96 3.60 .00
Renal failure 0.86 0.78 0.94 3.25 .00
Race 0.89 0.83 0.96 3.19 .00
2 or more reoperations 0.34 0.15 0.77 2.58 .01
CVD 0.94 0.89 0.99 2.42 .02
Diabetes 0.95 0.92 0.99 2.41 .02
PVD 0.95 0.91 1.00 2.03 .04
NYHA class IV 0.97 0.92 1.01 1.50 .13
Creatinine 0.98 0.95 1.01 1.27 .20
Left main disease 1.00 0.96 1.04 0.13 .90
Negative t values indicate a negative propensity for ITA grafting preoper-
atively. Positive t values indicate a propensity for ITA grafting.
BSA, Body surface area; IABP, intra-aortic balloon pump; CHF, congestive
heart failure; MI, myocardial infarction; CVA, cerebrovascular accident
(stroke, permanent); CVD, cerebrovascular disease; PVD, peripheral vas-
cular disease; NYHA, New York Heart Association.
TABLE 5. Propensity score analysis
Mortality rates
Propensity score Total patients ITA (%) No ITA ITA 
0.01-0.59 19,988 38.5 6.91 6.57 0.34
0.59-0.78 19,989 69.1 5.48 4.65 0.83
0.78-0.88 19,988 84.0 5.35 4.17 1.18
0.88-0.95 19,989 92.0 5.52 3.69 1.83
0.95-1.0 19,988 97.8 5.15 2.86 2.29
After assigning a propensity score to all patients, patients were grouped by
propensity score into 5 propensity score categories from low to high.
Within each grouping, the mortality on the basis of whether the patient
received an ITA was compared. All 5 categories demonstrated improve-
ment in mortality with ITA grafting. Although the greatest benefit was seen
in the patients with the highest propensity score (the greatest likelihood of
receiving an ITA on the basis of preoperative variables), even the patients
in the lowest propensity score grouping showed a protective effect of ITA
grafting. The average difference in mortality rate was 1.29 Mantel-Haens-
zel test for association between mortality and ITA use: P  .0001.
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ton continues to increase; from 1990 to 1999, the mean age
of patients presenting for surgical intervention in the STS
NCD increased from 65.2 to 66.7 years (P .0001), and the
percentage of patients older than 75 years increased by
3.4%.15
Benefits of ITA Grafting: Acute Mortality
The effect of ITA grafting on acute (in-hospital or 30-day)
mortality is more clearly understood. Cosgrove and col-
leagues,26 in 1986, documented that the use of ITA grafting
did not increase operative mortality. Gardner and cowork-
ers27 reported, in 1990, on the safety and efficacy of ITA
grafting in an elderly (defined as 70 years of age) popu-
lation from a single institution. Beginning in 1994, docu-
mentation of an improved acute survival benefit from ITA
grafting was demonstrated from voluntary (STS) and com-
pulsory (VA) databases.7,9 Recently, Sergeant and associ-
ates28 could not demonstrate any influence of single, mul-
tiple, sequential, or complete arterial revascularization on
early survival after CABG for reasons thought to be related
to the unique European data set. In the Lytle studies24,25 the
early hazard phase comparing the 2 arterial grafting strate-
gies demonstrated that ITA grafting to the LAD conveyed
an acute (in-hospital) survival benefit; female sex, age, left
ventricular dysfunction, and peripheral vascular disease in-
creased the early hazard risk of death.
Data from this study demonstrate for the first time sim-
ilar beneficial results in a substantial population of patients
75 years or older. A 40% decrease in unadjusted mortality
was seen (Table 2), along with a significant decline in
risk-adjusted mortality, by using analyses that account for
the patient selection and site effects that can confound
observational data set analyses (Tables 3 and 5).
In Table 1, 24% of patients had left main disease of
greater than 50%, and 73% had three-vessel disease. Thus
the number of patients who were revascularized without a
left ITA graft to the LAD because of the absence of ana-
tomic disease in the LAD was small, and in most cases the
lack of ITA grafting was due to physician choice and not
anatomically based. By means of univariate analysis (Table
1), the group not undergoing ITA grafting appeared to be at
higher risk on the basis of preoperative risk factor variables
and had a higher incidence of risk factors that could poten-
tially contribute to complications related to ITA grafting,
namely congestive heart failure, chronic lung disease, pre-
operative renal failure-dialysis, left main disease (50%),
and urgent operative status. Each of these conditions might
dissuade a surgeon from electing to perform an ITA graft in
a selected patient. The present study suggests, however, that
ITA grafting should be used in these patients for the acute
perioperative mortality benefit.
Patient Subgroups Associated With ITA Grafting in
the Elderly
In Figure 2 all 5 predicted risk subgroups (low to high risk)
showed a trend toward improvement in mortality in the ITA
group. These data suggest that ITA grafting in the elderly
conveys an acute survival advantage across all levels of
preoperative risk. These results are consistent with prior
analyses by Edwards and colleagues7 and the Northern New
England Cardiovascular Study group29 in younger patient
groups. The relative risk reduction conveyed by ITA use is
less in the elderly than that reported previously in younger
patients; however, given that elderly patients have a higher
baseline risk, the absolute risk reduction is similar or greater
in magnitude in the elderly.
Figure 3. Multivariable logistic regression analysis of interaction. ITA use interacted significantly with age and EF.
Data are expressed as OR of survival with 95% CIs. A value of less than 1.0 indicates a beneficial effect of ITA
grafting on survival for that subset. For age, patient numbers include the following: age 75-79 years, 67,643; 80-84
years, 26,644; and 85 years and older, 5655. For EF, patient numbers include the following: EF 45 and higher, 74,691;
30-45, 20,148; and less than 30, 5103.
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The analysis of interaction between ITA grafting and
other variables yielded 2 interactions that were significant,
namely age and EF. Both increasing age and decreasing EF
are independently associated with an overall mortality in-
crease after CABG.1,3,4,16 Figure 3 illustrates, in a format
useful for clinicians, that the survival benefit of ITA grafting
declines with increasing age at operation and with decreas-
ing preoperative EF. Clinicians are cautioned, however, that
these are post hoc subgroup analyses and should be viewed
in the context of the overall survival benefit demonstrated
for this population. Confirmation of these subgroup findings
in other databases is suggested. Also, this analysis examined
only acute mortality benefits, and these groups may still
have long-term benefits from ITA.
Perioperative Complications
Use of the ITA graft was also generally not associated with
an overall increase in perioperative morbidity risk in this
elderly population. Of the 5 major complication end points
used in the STS risk-assessment model shown in Table 3,
prolonged ventilation was decreased significantly compared
with that seen in the group not receiving an ITA graft, and
the incidences of stroke, reoperation, and renal failure were
not statistically different and, importantly, were not in-
creased. The incidence of mediastinitis in the group receiv-
ing an ITA graft was significantly increased, however, and
thus the relative risk was higher in the this group. However,
the absolute risk in the group receiving an ITA graft was
still less than 1.0% (Table 2), which was actually less than
in the NCD as a whole for this time interval15 and was less
than that reported by Lytle and colleagues24 and less than
the Northern New England Cardiovascular Study Group
(NNE) reported,29,30 despite the significantly older popula-
tion in this STS analysis. Thus the potential for complica-
tions should not a priori dissuade surgeons from the use of
ITA grafts in this elderly patient population.
Propensity Score Analysis
The propensity score analysis we performed demonstrated
that in each of 5 quintiles of patients, ranging from low to
high propensity for receiving an ITA graft on the basis of
preoperative variables, the use of an ITA graft also had a
protective effect compared with that seen patients in that
quintile group who did not receive an ITA graft. The mag-
nitude of benefit increased with the increasing propensity to
use an ITA graft, as would be expected; however, even in
the lowest propensity quintile group ITA grafting was of
benefit. Similarly, a matched-pairs analysis (matching pa-
tients with similar baseline likelihood for getting an ITA)
found that those who actually received an ITA had signif-
icantly lower risk for acute mortality (OR, 0.73; 95% CI,
0.69-0.76). Importantly, this study documented that even
elderly patients who, on the basis of preoperative risk fac-
tors, would least likely be considered candidates for an ITA
graft derive a survival benefit from use of this arterial
conduit. As such, age alone should not exclude patients
from consideration for ITA grafting.
Quality of Care Implications
Figure 1 and the survey data (see Appendix) suggest that in
the STS NCD, ITA grafting in elderly patients may be
underused compared with younger patients. Although ITA
use over the past 5 years has increased in the elderly
population parallel to that seen in the overall NCD, the rate
of use remains some 10% to 15% less. In addition, a wide
distribution of ITA use exists among the almost 500 sites
that participated in the NCD in this contemporary time
frame. Variance between a site’s perceptions about their
practices and the actual use data were documented in the
survey. A mean estimate of 83.3% was given as the per-
centage use of ITA at their site compared with the 77.4%
documented in this analysis. In addition, over one fifth of
sites reported the sentiment that ITA grafting in the elderly
was not beneficial.
These results parallel earlier observations from the NNE
group30 and the Alabama Quality Assurance Foundation
CABG Cooperative Project11 that there can be widespread
variability in use of the ITA as a conduit between centers.
Importantly, both the NNE and Alabama Quality Assurance
Foundation projects identified ITA grafting as a process of
care suitable for quality improvement bench marking, and
both have demonstrated significant increases in ITA use in
their patient populations.29,31
Taken together, Figure 1 and the survey data suggest that
additional justification for the use of the ITA in these elderly
patients will be necessary to change physician behavior. The
beneficial effect on operative survival (at least in patients
85 years) in the absence of a significant risk of increased
complications demonstrated in the present study may pro-
vide that additional justification.
ITA grafting thus should be considered for use as a
quality indicator in patients of all ages undergoing CABG.
As a process measure, it has the advantage that it is well
standardized and is a discrete component of the surgical
procedure. Moreover, the decision to use or not to use an
ITA in these elderly patients is almost solely the responsi-
bility of the operating surgeon. This focuses the associated
quality-improvement efforts at the surgeon as an individual
practitioner and to all cardiac surgeons as a group through
the STS NCD. This greatly facilitates the mechanisms by
which the specific behavior regarding this process of care
and the beneficial effect on these patients can be positively
influenced.32 Table 4 provided insight to the preoperative
risk factors on which physician bias for or against ITA use
may be based.
Possible Mechanism of Benefit
The reasons for the improvement in acute survival of ITA
grafting (for all ages) remain unclear. However, there are
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several possible explanations applicable to this elderly pop-
ulation. The quality of the greater saphenous vein may be
less than in a younger patient, which in turn may lead to a
decreased incidence of early graft failure caused by throm-
botic complications. Decreasing the number of proximal
anastomoses might also be beneficial in elderly patients
with aortic disease. The important physiologic benefits of an
arterial graft may also contribute to early graft patency in
senescent and often calcified coronary arterial trees and
under conditions of extensive distal disease, where com-
plete revascularization may be less technically feasible.22,33
Finally, given the greater than 90% use of ITA grafting to
the anterior heart in younger patients, surgeons may be
performing a different operation when they attempt to graft
a saphenous vein graft to the LAD in the elderly.
Limitations
This study was a nationwide, multisite observational study.
One criticism of observational studies is that patients who
receive an intervention (that is shown to be beneficial) are
not as high risk as those who do not. Moreover, multisite
observational studies should control for the confounding
because of between-site effects as well. Both issues have
been addressed in the statistical analyses in this study.
In addition, the study is limited by the nature of large,
multisite voluntary databases. Recent studies, however,
have documented that the data quality in the NCD is similar
to that in other mandatory database efforts in cardiovascular
surgical disease.12,15 The study is also limited by the rela-
tively small number of patients in the older than 85-year
subgroup; we will continue to follow this group of patients
closely as more and more of them present for surgical
intervention in the next few years.
Elderly patients presenting for CABG under emergency-
salvage circumstances were excluded from this analysis,
and conclusions about the benefits of ITA grafting should
probably not be extended to this subgroup.
Finally, this study focused only on the acute (30-day)
survival benefit of ITA grafting. Although it may be possi-
ble to extrapolate the long-term benefits seen in younger
patients to this elderly group, this requires further confir-
mation.
Conclusions
We found a similar acute survival advantage among very
elderly patients, as has previously been demonstrated
among younger patients presenting for elective or urgent
CABG. This benefit can be realized without a substantial
increased risk of perioperative complications. Thus sur-
geons should strongly consider use of an ITA graft to the
LAD in all patients presenting for elective or urgent revas-
cularization, regardless of age.
We also found that ITA grafting is underused in the
elderly. The number of elderly patients coming to surgical
revascularization will continue to increase,15 and therefore
an improvement in overall CABG quality of care could be
realized through the incorporation of this process of care
into routine practice. The STS National Database provides
an opportunity to track this process of care over time and
can provide feedback to physicians to ensure evidence-
based care practices are provided to all patients.
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Discussion
Dr Timothy J. Gardner (Philadelphia, Pa). First, let me
compliment Dr Ferguson for an excellent presentation and for a
very sophisticated review, which puts the STS database to perhaps
its most valuable use, namely subspecialty-wide quality-improve-
ment purposes. The National Cardiac Surgery Database, which
was envisioned, planned, implemented, and nurtured by some of
the most dedicated members of the STS, as well as supported
financially by the Society during its initial development and sub-
sequent rescue from Summit Medical’s failure, has become an
extremely valuable resource both for our specialty and for our
patients.
The Federal Agency for Health Care Research and Quality’s
funding for the STS Database Committee under Bruce Ferguson’s
direction is really unique in medicine and carries with it the
expectation that such a specialty-initiated project as this one will
result in improvement in patient care broadly.
When I had the opportunity to address the Senate Appropria-
tions Committee and the President’s Bipartisan Commission on
Medicare Reform in 1998 to argue against cuts in Medicare
program support for cardiothoracic surgery, we were able to point
to this unique specialty database as evidence of thoracic surgeons’
commitment to quality improvement in the care of our Medicare
patients.
Now, it goes without saying that information and its analysis—
appropriate analysis—are empowering, and this study provides an
exemplary illustration of this fact. As Dr Ferguson mentioned, we
thought we noted a possible survival benefit in our elderly patients
receiving ITA grafts about 10 years ago, but our series was
relatively small, and we could not eliminate the possibly confound-
ing influence of patient selection bias on the results and on our
conclusions.
In this present analysis, which relies on large numbers of
patients from multiple centers and uses detailed and sophisticated
preoperative risk stratification, the conclusion about the benefit of
ITA use on patient survival, regardless of patient risk class, is
compellingly clear. As in previous studies looking at younger
patients, this analysis demonstrated the early and late survival
benefit conferred by in situ ITA grafting of the LAD in patients 75
years or older. Can it be any clearer than this? Whenever an ITA
graft is used, the recipient, even an elderly patient, is more likely
to survive the operation.
Bruce, I would like to emphasize a couple of observations made
here and ask a question. First, the incidence of prolonged postop-
erative ventilation in the elderly ITA graft population was actually
lower than that seen in the no-ITA-graft patients. And I am sure
others have occasionally avoided ITA use in patients with severe
preoperative respiratory insufficiency or chronic obstructive pul-
monary disease, assuming that ITA harvest and left pleural entry
might increase the likelihood of difficulty weaning the patient from
the ventilator. This was apparently not the case in these patients,
and I wonder if you have any comments on that.
Second, there was, on the other hand, a significantly higher
incidence of deep sternal wound infection in the ITA-harvested
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patients, although you point out that it was statistically significant
but not a high occurrence rate. Do you believe that there are
surgical techniques that ought to be considered in elderly patients
having ITA takedown that might reduce the likelihood of sternal
infection, such as a shorter segment of ITA harvest or whatever?
Lastly, you stated in the article, and you said again here, that
ITA grafting could and perhaps should be used as a quality
indicator in our review of our experience with patients undergoing
CABG. Would you elaborate on how such an analysis can and
should be made, and would you perhaps suggest what percentage
of ITA use would be considered an appropriate quality indicator?
Dr Ferguson. Thank you very much, Dr. Gardner, for your
nice comments, and, again, it was your study published from
Hopkins 10 years ago that really introduced the concept of doing
ITA grafting in the elderly population. Unfortunately, they con-
tinue to get older, and we continue to operate on them.
The incidence of prolonged ventilation was actually shorter in
the ITA group. It is of interest that this is also true if one looks at
the entire STS national data set and also other large data sets,
including Northern New England. We all have a presumption that
patients with severe chronic obstructive pulmonary disease would
probably not do as well if we took an ITA graft. But at least the
data that are out there from these large data sets do not seem to
bear that out.
With regard to the deep sternal infection, that was obviously the
only negative finding in this study. The good news is that the
incidence still remains well below 1%, but I think we have to say
that in elderly patients harvesting an ITA may result in a slightly
increased incidence of deep sternal infection. I think taking a
shorter pedicle and using particular techniques of trying to avoid as
much electrocautery of the sternum in these fragile patients who
have very fragile tissues is a wise surgical approach to take.
We did not analyze the use of bilateral ITA grafting in this
patient subset, so I cannot comment on that.
Finally, you mentioned the issue of quality improvement and
using ITA grafting as a quality improvement indicator. This has
been done in a number of regional settings, such as the Alabama
Quality Assurance Foundation studies led by Dr Bill Homan and
others. This STS effort is the first to attempt to demonstrate this on
a national level.
As I mentioned, ITA grafting is a very important process
measure because the surgeon decides whether to do an ITA graft.
So if we are going to accept the fact that ITA grafting is beneficial
for the operative mortality of a particular patient, then it is the
surgeon—and only the surgeon in this case—who really needs to
be convinced of that. If we look at the fact that 26% of the surgical
sites surveyed say they did not think ITA grafting was going to be
beneficial, those are the 26% whose preconceptions we need to
change. They need to become convinced how this technique could
be used as a mechanism to actually improve outcomes, in that if we
do more ITA grafting in elderly patients, their operative mortality
will go down.
Dr Bruce J. Leavitt (Burlington, Vt). This article discusses the
use of the ITA graft as a conduit for CABG in the elderly patient
population. This is the second reported study of ITA use in elderly
patients having CABG. The Northern New England Cardiovascu-
lar Study Group, or NNE, recently reported that the use of the left
ITA graft improved hospital mortality in patients undergoing by-
pass surgery. The protective effect was seen in all groups of
patients and especially noted in the patients who were over 70
years of age. Our study included those patients having emergency
surgical revascularization, which was 7% of the total, and in our
calculations there was a 70% reduction of perioperative mortality
in those patients who received an ITA graft.
Also in our study, 4% of the patients received bilateral ITA
grafts or a right ITA graft. In your study these patients were
excluded. The risk of mediastinitis was low but significantly in-
creased in your study. We found a trend toward a lower rate of
mediastinitis in any group, but this was based on our entire
population and not just those older than 70 years. Dr Ferguson,
looking at your data, it does appear that even though the use of ITA
in the elderly is low, the greatest room for improvement in the ITA
use is in groups that are over 70 years of age.
I have 3 points and 4 questions.
First, this article confirms our findings that the presence of an
ITA graft is protective for a reduction in in-hospital mortality. Do
you believe there is room for process improvement in all age
groups, specifically in regard to ITA use? Second, why were
emergency patients left out? We found a significant benefit in
those groups. Third, did you consider the use of bilateral ITA or
right ITA grafts in your study? And fourth, did you look at the
trends of ITA use over time, and were there any changes in
mortality during that period?
Dr Ferguson. Thanks, Bruce. I would like to congratulate the
Northern New England group for having challenged us, and I think
we have developed a very, very excellent collaborative relation-
ship with them.
With regard to your questions, we excluded emergency cases
because of the difficulty in the categorization of these cases and the
presumption that that would, for the purposes of this analysis,
make it more difficult to convey the message we were hoping to
convey.
ITA grafting is a process-improvement tool. It has been used in
all age groups. In younger patients use rates are currently 90% in
the STS, 90% in Northern New England, and 90% in this age
population in the State of Alabama. The question in this subset is
why is it not 100%?
We did not do an analysis of bilateral ITA grafting. We have
done an analysis of trends over time, in large part because of some
earlier Northern New England reports. The actual incidence of ITA
grafting overall in the national database has increased from 49% at
the time of the Edwards publication in 1994 to 84% in this most
recent analysis. So we have understood the message partially. We
just have not understood it completely.
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